ON Helix 2025 New Horizons for Bio Innovation Join us in Cambridge on 3 July 2025. One-day conference addresses key bio innovation trends, from developments in life science and technology […]
Resolian is exhibiting at ISSX 2025 in Chicago. Join us.
Resolian is exhibiting at Joint Pharmaceutical Analysis Group. Dissolution: From Method Development to Approval - a JPAG Foundations Event Join us.
Join us at AusBiotech 2025. For decades, the AusBiotech conference has served as the leading international meeting place for the Australian life science community. Biotechnology continues to unlock vast […]
Join us at AAPS PharmSci 360. PharmSci brings together leading researchers from academia and industry. You will hear about the latest in cutting edge science.
American College of Toxicology. 46th Annual Meeting (2025) The Annual Meeting is the heart of ACT. Our November gathering brings together a community of toxicologists at venues conducive to […]
European Bioanalysis Forum 18th EBF Open Symposium. Tuning into Tomorrow - Science in High Definition. Join us at EBF 2025 - Booth 18.
Resolian is exhibiting at Joint Pharmaceutical Analysis Group. JPAG Regulatory Hot Topics Join us.
Chief Scientific Officer
Zhiyang Zhao, Ph.D., serves as Chief Scientific Officer (CSO) at Resolian. Dr. Zhao has over 30 years of pharmaceutical industry experience with special focus on drug metabolism and bioanalysis of small and large molecules in drug discovery and development. Dr. Zhao has previously held positions at Pfizer, GlaxoSmithKline, and Amgen. Before joining Resolian in 2015, Dr. Zhao served as Site Director of Preclinical Research at Amgen in Cambridge, Massachusetts, for over a decade.
Currently, Dr. Zhao serves as an Adjunct Professor at the Eshelman School of Pharmacy of the University of North Carolina at Chapel Hill, North Carolina, and as Editor-in-Chief of Drug Metabolism & Bioanalysis Letters, a journal by Bentham Science, which publishes in all areas of drug metabolism and bioanalysis. Dr. Zhao received his Ph.D. degree in Medicinal Chemistry from Virginia Polytechnic and State University (popularly known as Virginia Tech) in Blacksburg, Virginia.
Chief Executive Officer
Patrick Bennett has over 35 years of experience in pharmaceutical analysis and laboratory management. Now Chief Business Officer at Resolian, Patrick’s experience includes the roles of Strategic Marketing Director for Pharma with Thermo Fisher Scientific, LabCorp, and Vice President of Strategy and Development with PPD.
Patrick earned a B.S. degree in Toxicology and a M.S. degree in Pharmacology from the College of Pharmacy and Allied Health at St. John’s University and an M.B.A in International Marketing from the Martin J. Whitman School of Management at Syracuse University.